The effect of integrating screening and management of depressive symptoms on quality of life and symptom burden among patients living with cancer at Kamuzu Central Hospital in Malawi.

Integrating screening and management of depressive symptoms among patients living with cancer.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202303734043508

Enrollment

198

Registered

2023-03-14

Start date

2021-07-19

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Mental and Behavioural Disorders

Interventions

screen and treat for depressive symptoms using an integrated approach

Screen and refer all patients with diagnosed depressive symptoms to mental health clinic

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All adult patients aged above 18 years and had cancer were included in the study.

Exclusion criteria

Exclusion criteria: Those who did not consent for the study and were not able to respond to the questions were excluded.

Design outcomes

Primary

Measure	Time frame
Remission of depressive symptoms;Quality of life	—

Secondary

Measure	Time frame
Feasibility, acceptability and appropriateness of integrating screening and treatment for depressive symptoms	—

Countries

Malawi

Contacts

Public ContactMichael Udedi

Mentor

mphatsoudedi@yahoo.co.uk00265994253002

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026